UF Innovate | Sid Martin Biotech Resident Company Lacerta Therapeutics, Inc. Closes On $30 million Investment Round (Business Wire)
UF Innovate | Sid Martin Biotech, the leading biotechnology incubator at the University of Florida, announces resident company Lacerta Therapeutics, Inc., has... Read More
Sarepta Carries Lacerta Through $30M Round (Global University Venturing)
UF Innovate | Sid Martin Biotech resident client Lacerta Therapeutics, a US-based gene therapy startup of University of Florida, received $30m in... Read More
Oragenics, Inc. Resumes Phase 2 Clinical Trial of AG013 in Oral Mucositis Following Positive Routine Safety Review (Business Wire)
UF Innovate | Sid Martin alumni startup Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective... Read More
AxoGen Invests $5M in Dayton, Ohio, Site for Expanded Operations (Dayton Daily News)
UF startup and UF Innovate | Sid Martin Biotech alum AxoGen, a medical devices manufacturer, has purchased a Vandalia building and land... Read More
Blood Test May Eliminate Need for CT Scans after TBI (Healio)
The University of Rochester School of Medicine and Dentistry studied the accuracy of a TBI diagnostic blood test created by UF startup... Read More
Sarepta Dives Deeper into Gene Therapy (PharmaPhorum)
Sarepta Therapeutics has handed $30 million to UF startup and Sid Martin Biotech resident client Lacerta in exchange for a group of... Read More
New Diagnostic Blood Test Developed for Concussions (eHealth News)
UF biotech company, Banyan Biomarkers, Inc. has developed the first blood test that can be used by physicians to objectively aid in the... Read More
AxoGen, Inc Common Stock (AXGN) Sets New 1-Year High at $56.85 (Fairfield Current)
UF startup and Sid Martin Biotech alum AxoGen, Inc reported that its Common Stock (NASDAQ:AXGN) shares hit a new 52-week high during... Read More
Ology Bioservices and RAFA Laboratories Announce FDA Approval of the Atropine Autoinjector as a Medi (BioFlorida)
UF startup and Sid Martin Biotech alum Ology Bioservices, Inc., a biologics contract development and manufacturing organization, and Rafa Laboratories, Ltd., a... Read More
AGTC Treats First Patient of Second Cohort in Phase 1/2 Clinical XLRP Study; Earns $10 Million Enrollment Milestone (BioFlorida)
Applied Genetic Technologies Corporation, a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare... Read More